Cargando…
Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors
Natural products based on imidazole scaffolds have inspired the discovery of a wide variety of bioactive compounds. Herein, a series of imidazoles that act as competitive and potent cruzain inhibitors was investigated using a combination of ligand- and structure-based drug design strategies. Quantit...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071344/ https://www.ncbi.nlm.nih.gov/pubmed/33920961 http://dx.doi.org/10.3390/biom11040579 |
_version_ | 1783683678728093696 |
---|---|
author | Medeiros, Alex R. Ferreira, Leonardo L. G. de Souza, Mariana L. de Oliveira Rezende Junior, Celso Espinoza-Chávez, Rocío Marisol Dias, Luiz Carlos Andricopulo, Adriano D. |
author_facet | Medeiros, Alex R. Ferreira, Leonardo L. G. de Souza, Mariana L. de Oliveira Rezende Junior, Celso Espinoza-Chávez, Rocío Marisol Dias, Luiz Carlos Andricopulo, Adriano D. |
author_sort | Medeiros, Alex R. |
collection | PubMed |
description | Natural products based on imidazole scaffolds have inspired the discovery of a wide variety of bioactive compounds. Herein, a series of imidazoles that act as competitive and potent cruzain inhibitors was investigated using a combination of ligand- and structure-based drug design strategies. Quantitative structure–activity relationships (QSARs) were generated along with the investigation of enzyme–inhibitor molecular interactions. Predictive hologram QSAR (HQSAR, r(2)(pred) = 0.80) and AutoQSAR (q(2) = 0.90) models were built, and key structural properties that underpin cruzain inhibition were identified. Moreover, comparative molecular field analysis (CoMFA, r(2)(pred) = 0.81) and comparative molecular similarity indices analysis (CoMSIA, r(2)(pred) = 0.73) revealed 3D molecular features that strongly affect the activity of the inhibitors. These findings were examined along with molecular docking studies and were highly compatible with the intermolecular contacts that take place between cruzain and the inhibitors. The results gathered herein revealed the main factors that determine the activity of the imidazoles studied and provide novel knowledge for the design of improved cruzain inhibitors. |
format | Online Article Text |
id | pubmed-8071344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80713442021-04-26 Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors Medeiros, Alex R. Ferreira, Leonardo L. G. de Souza, Mariana L. de Oliveira Rezende Junior, Celso Espinoza-Chávez, Rocío Marisol Dias, Luiz Carlos Andricopulo, Adriano D. Biomolecules Article Natural products based on imidazole scaffolds have inspired the discovery of a wide variety of bioactive compounds. Herein, a series of imidazoles that act as competitive and potent cruzain inhibitors was investigated using a combination of ligand- and structure-based drug design strategies. Quantitative structure–activity relationships (QSARs) were generated along with the investigation of enzyme–inhibitor molecular interactions. Predictive hologram QSAR (HQSAR, r(2)(pred) = 0.80) and AutoQSAR (q(2) = 0.90) models were built, and key structural properties that underpin cruzain inhibition were identified. Moreover, comparative molecular field analysis (CoMFA, r(2)(pred) = 0.81) and comparative molecular similarity indices analysis (CoMSIA, r(2)(pred) = 0.73) revealed 3D molecular features that strongly affect the activity of the inhibitors. These findings were examined along with molecular docking studies and were highly compatible with the intermolecular contacts that take place between cruzain and the inhibitors. The results gathered herein revealed the main factors that determine the activity of the imidazoles studied and provide novel knowledge for the design of improved cruzain inhibitors. MDPI 2021-04-15 /pmc/articles/PMC8071344/ /pubmed/33920961 http://dx.doi.org/10.3390/biom11040579 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Medeiros, Alex R. Ferreira, Leonardo L. G. de Souza, Mariana L. de Oliveira Rezende Junior, Celso Espinoza-Chávez, Rocío Marisol Dias, Luiz Carlos Andricopulo, Adriano D. Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors |
title | Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors |
title_full | Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors |
title_fullStr | Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors |
title_full_unstemmed | Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors |
title_short | Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors |
title_sort | chemoinformatics studies on a series of imidazoles as cruzain inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071344/ https://www.ncbi.nlm.nih.gov/pubmed/33920961 http://dx.doi.org/10.3390/biom11040579 |
work_keys_str_mv | AT medeirosalexr chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors AT ferreiraleonardolg chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors AT desouzamarianal chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors AT deoliveirarezendejuniorcelso chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors AT espinozachavezrociomarisol chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors AT diasluizcarlos chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors AT andricopuloadrianod chemoinformaticsstudiesonaseriesofimidazolesascruzaininhibitors |